Back to search

Article

Newborn Screening for Inherited Metabolic Diseases Using Tandem Mass Spectrometry in China: outcome and cost-utility analysis

2020-12-11

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>Few studies in China have focused on economic evaluation of newborn screening(NBS) for inherited metabolic diseases (IMDs) by tandem mass spectrometry (MS/MS). This study assessed the total costs, benefits, benefit-cost ratio(BCR), cost-utility ratio(CUR) and incremental cost-utility ratio(ICUR) of NBS using MS/MS compared to non-screening group for the first time...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
03dc53da-bcb3-58a6-9462-9f8b07d6a08e
DOI
10.21203/rs.3.rs-124404/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Newborn Screening for Inherited Metabolic Diseases Using Tandem Mass Spectrometry in China: outcome and cost-utility analysisDOI 10.21203/rs.3.rs-124404/v1
Select a neighboring publication to make it the new centre.